Skip to main content
Erschienen in: Reactions Weekly 1/2017

01.06.2017 | Case report

Amoxicillin/clavulanic acid/tolvaptan

Liver injury: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Drug overdose …
Literatur
Zurück zum Zitat Watkins PB, et al. Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database. Drug Safety 38: 1103-1113, No. 11, Nov 2015. Available from: URL: http://doi.org/10.1007/s40264-015-0327-3 - USA Watkins PB, et al. Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database. Drug Safety 38: 1103-1113, No. 11, Nov 2015. Available from: URL: http://​doi.​org/​10.​1007/​s40264-015-0327-3 - USA
Metadaten
Titel
Amoxicillin/clavulanic acid/tolvaptan
Liver injury: 3 case reports
Publikationsdatum
01.06.2017
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-31106-7

Weitere Artikel der Ausgabe 1/2017

Reactions Weekly 1/2017 Zur Ausgabe

Case report

Isotretinoin

Case report

Evolocumab

Case report

Fluorouracil